Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 12.

Le Rhun, E; Weller, M; Brandsma, D; Van den Bent, M; de Azambuja, E; Henriksson, R; Boulanger, T; Peters, S; Watts, C; Wick, W; Wesseling, P; Rudà, R; Preusser, M; EANO Executive Board; ESMO Guidelines Committee (2017). EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Annals of Oncology, 28(suppl_4):iv84-iv99.

Goldbrunner, Roland; Minniti, G; Preusser, M; Jenkinson, M D; Sallabanda, K; Houdart, E; von Deimling, A; Stavrinou, P; Lefranc, F; Lund-Johansen, M; Moyal, E C; Brandsma, D; Henriksson, R; Soffietti, R; Weller, M (2016). EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncology, 17(9):e383-e391.

Roth, P; Preusser, M; Weller, M (2016). Immunotherapy of Brain Cancer. Oncology Research and Treatment, 39(6):326-334.

Furtner, J; Schöpf, V; Seystahl, K; Le Rhun, E; Rudà, R; Roelcke, U; Koeppen, S; Berghoff, A S; Marosi, C; Clement, P; Faedi, M; Watts, C; Wick, W; Soffietti, R; Weller, M; Preusser, M (2016). Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. Neuro-Oncology, 18(3):401-407.

Preusser, M; Roth, P (2015). New frontiers in neurooncology. Current Opinion in Neurology, 28(6):626-627.

Preusser, M; Berghoff, A S; Wick, W; Weller, M (2015). Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma? Clinical Neuropathology, 34(6):313-321.

Berghoff, A S; Kiesel, B; Widhalm, G; Rajky, O; Ricken, G; Wöhrer, A; Dieckmann, K; Filipits, M; Brandstetter, A; Weller, M; Kurscheid, S; Hegi, M E; Zielinski, C C; Marosi, C; Hainfellner, J A; Preusser, M; Wick, W (2015). Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. Neuro-Oncology, 17(8):1064-1075.

Hoang-Xuan, K; Bessell, E; Bromberg, J; Hottinger, A F; Preusser, M; Rudà, R; Schlegel, U; Siegal, T; Soussain, C; Abacioglu, U; Cassoux, N; Deckert, M; Dirven, C M; Ferreri, A J; Graus, F; Henriksson, R; Herrlinger, U; Taphoorn, M; Soffietti, R; Weller, M (2015). Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncology, 16(7):e322-332.

Preusser, M; Weller, M (2015). Brain metastasis research: a late awakening. Chinese Clinical Oncolog, 4(2):17.

Berghoff, A S; Kovanda, A K; Melchardt, T; Bartsch, R; Hainfellner, J A; Sipos, B; Schittenhelm, J; Zielinski, C C; Widhalm, G; Dieckmann, K; Weller, M; Goodman, S L; Birner, P; Preusser, M (2014). αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. Clinical & Experimental Metastasis, 31(7):841-851.

Berghoff, A S; Rajky, O; Winkler, F; Bartsch, R; Furtner, J; Hainfellner, J A; Goodman, S L; Weller, M; Schittenhelm, J; Preusser, M (2013). Invasion patterns in brain metastases of solid cancers. Neuro-Oncology, 15(12):1664-1672.

Preusser, M; de Ribaupierre, S; Wöhrer, A; Erridge, S C; Hegi, M; Weller, M; Stupp, R (2011). Current concepts and management of glioblastoma. Annals of Neurology, 70(1):9-21.

This list was generated on Mon Sep 23 11:47:10 2019 CEST.